Concepts (90)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Influenza A Virus, H7N9 Subtype | 1 | 2017 | 415 | 0.50 | Why? |
| Antibodies, Viral | 12 | 2021 | 51949 | 0.37 | Why? |
| Influenza Vaccines | 3 | 2020 | 2941 | 0.34 | Why? |
| Epidemiological Monitoring | 1 | 2020 | 3493 | 0.34 | Why? |
| Spike Glycoprotein, Coronavirus | 6 | 2021 | 37182 | 0.26 | Why? |
| Antigens, Viral | 1 | 2020 | 6298 | 0.25 | Why? |
| Influenza A Virus, H1N1 Subtype | 3 | 2020 | 2984 | 0.21 | Why? |
| Seroconversion | 2 | 2020 | 2515 | 0.20 | Why? |
| Influenza, Human | 3 | 2020 | 10779 | 0.19 | Why? |
| Hemagglutinins | 1 | 2019 | 143 | 0.18 | Why? |
| Antibodies, Monoclonal | 1 | 2017 | 8041 | 0.18 | Why? |
| Antibodies, Neutralizing | 3 | 2021 | 25288 | 0.17 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.15 | Why? |
| Virus Physiological Phenomena | 1 | 2017 | 155 | 0.15 | Why? |
| Mobile Health Units | 1 | 2021 | 741 | 0.13 | Why? |
| T-Lymphocyte Subsets | 1 | 2021 | 1387 | 0.13 | Why? |
| Ferrets | 1 | 2019 | 1201 | 0.13 | Why? |
| Enzyme-Linked Immunosorbent Assay | 4 | 2021 | 7868 | 0.12 | Why? |
| Orthomyxoviridae Infections | 1 | 2019 | 1001 | 0.11 | Why? |
| Vaccines, Inactivated | 1 | 2019 | 1562 | 0.11 | Why? |
| Hemagglutinin Glycoproteins, Influenza Virus | 3 | 2020 | 511 | 0.11 | Why? |
| Military Personnel | 1 | 2021 | 1097 | 0.10 | Why? |
| Nicaragua | 2 | 2020 | 71 | 0.10 | Why? |
| Urban Population | 1 | 2020 | 2000 | 0.10 | Why? |
| New York City | 2 | 2021 | 7432 | 0.10 | Why? |
| Recombinant Proteins | 1 | 2020 | 3786 | 0.10 | Why? |
| HEK293 Cells | 1 | 2020 | 8394 | 0.08 | Why? |
| Drug Discovery | 1 | 2017 | 3092 | 0.06 | Why? |
| Ambulatory Care | 1 | 2020 | 4947 | 0.06 | Why? |
| Infant, Newborn | 2 | 2020 | 23105 | 0.06 | Why? |
| Immunogenetic Phenomena | 1 | 2021 | 61 | 0.06 | Why? |
| Infant | 2 | 2020 | 30274 | 0.05 | Why? |
| Electrophoresis, Polyacrylamide Gel | 1 | 2020 | 238 | 0.05 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.05 | Why? |
| Child, Preschool | 2 | 2020 | 36283 | 0.05 | Why? |
| Hemagglutination Inhibition Tests | 1 | 2019 | 191 | 0.05 | Why? |
| Humans | 15 | 2021 | 930598 | 0.05 | Why? |
| Cross Reactions | 2 | 2021 | 4374 | 0.05 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.05 | Why? |
| Neuraminidase | 1 | 2020 | 289 | 0.04 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2021 | 9706 | 0.04 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.04 | Why? |
| Adult | 8 | 2021 | 244371 | 0.04 | Why? |
| Madin Darby Canine Kidney Cells | 1 | 2019 | 640 | 0.04 | Why? |
| Child | 3 | 2020 | 70012 | 0.04 | Why? |
| Cross Protection | 1 | 2019 | 373 | 0.04 | Why? |
| Neutralization Tests | 2 | 2020 | 6698 | 0.04 | Why? |
| Immunophenotyping | 1 | 2021 | 1290 | 0.04 | Why? |
| Adolescent | 3 | 2021 | 86841 | 0.04 | Why? |
| Male | 9 | 2021 | 367725 | 0.04 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.04 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.03 | Why? |
| Female | 8 | 2021 | 380317 | 0.03 | Why? |
| Immunization, Passive | 2 | 2020 | 10067 | 0.03 | Why? |
| Middle Aged | 6 | 2021 | 270681 | 0.03 | Why? |
| Area Under Curve | 1 | 2021 | 2564 | 0.03 | Why? |
| Vaccines, Attenuated | 1 | 2019 | 952 | 0.03 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.03 | Why? |
| Propensity Score | 1 | 2020 | 2690 | 0.03 | Why? |
| Dogs | 1 | 2019 | 2529 | 0.03 | Why? |
| Lymphocyte Activation | 1 | 2021 | 2742 | 0.03 | Why? |
| Case-Control Studies | 2 | 2020 | 17671 | 0.03 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.03 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2021 | 2262 | 0.03 | Why? |
| Immunization | 1 | 2019 | 2019 | 0.02 | Why? |
| Peptides | 1 | 2021 | 2513 | 0.02 | Why? |
| Risk | 1 | 2021 | 5288 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2021 | 3129 | 0.02 | Why? |
| Antibody Formation | 1 | 2021 | 4038 | 0.02 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.02 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.02 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2021 | 4545 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2020 | 9893 | 0.02 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2021 | 5837 | 0.02 | Why? |
| Aged | 4 | 2021 | 215776 | 0.02 | Why? |
| Virus Shedding | 1 | 2020 | 5834 | 0.02 | Why? |
| Cell Line | 1 | 2019 | 12040 | 0.02 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.02 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.01 | Why? |
| Biomarkers | 1 | 2021 | 23361 | 0.01 | Why? |
| Risk Assessment | 1 | 2021 | 25439 | 0.01 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.01 | Why? |
| Quarantine | 1 | 2021 | 18418 | 0.01 | Why? |
| Treatment Outcome | 1 | 2020 | 51732 | 0.01 | Why? |
| Vaccination | 1 | 2019 | 19050 | 0.01 | Why? |
| Infection Control | 1 | 2021 | 23131 | 0.01 | Why? |
| Animals | 1 | 2019 | 78931 | 0.01 | Why? |
| Retrospective Studies | 1 | 2020 | 105322 | 0.01 | Why? |
Stadlbauer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(90)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(174)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_